BiotechTube
Home/Lantheus Medical Imaging/Mary Anne Heino
MA

Mary Anne Heino

Executive Chairperson and Interim CEO

Lantheus Medical Imaging

Roles

Executive Chairperson and Interim CEOatLantheus Medical Imaging
Chief Executive Officer and PresidentatLantheus Holdings

Therapeutic Areas

OncologyNeurologyCardiology

Lantheus Medical Imaging Pipeline

DrugIndicationPhase
PYLARIFY (piflufolastat F 18)Prostate Cancer ImagingCommercial
LNTH-2401Metastatic Prostate CancerPhase 2
LNTH-2501/EVG-001 (Ga-68 edotreotide)Neuroendocrine TumorsRegulatory Filing
64Cu-LNTH-1363STumor/Fibrosis Assessment (Sarcoma)Phase 1/2A
LNTH-2503Small Cell Lung CancerPhase 1
LNTH-2505GlioblastomaPreclinical
LNTH-2507Pancreatic Ductal AdenocarcinomaPreclinical
LNTH-2509Lobular Breast CancerPreclinical